Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Post by u2bobon Jun 28, 2017 10:25am
159 Views
Post# 26413398

Interesting...

Interesting...Last week it was mentioned that Andre was in Mexico and was going to be stopping in the USA on the way back... anyone know who he was meeting with ? and if he is still in the states ?

I found the release of yesterdays NR about trading on the OTCQB yesterday ... and Andre being in the ststes good timing? or something else up...

Andre Larente, president of Diagnos, stated, "Allowing U.S.-based investors and brokers to be able to fully trade our common shares on a U.S. market will benefit Diagnos and all of its shareholders and is in line with our strategy to succeed in the U.S. health care market for the mass screening of diabetic retinopathy, which, if not detected at an early stage of development, can lead to blindness."

Whatever the case ADK looks like its wanting a reason to leave the gate in a big way...


Bullboard Posts